Biotech Bay
Filter News
Found 54,379 articles
-
Pfizer’s La Jolla cancer research center is set to grow by about 100 people. The pharma giant is transferring employees from a recently shuttered South San Francisco immunology site to bolster the work conducted near San Diego.
-
Orchard Therapeutics is expanding its physical footprint in California. The U.K.-based company signed a long-term lease to build out a gene therapy manufacturing facility in Fremont, Calif. The 150,000-square-foot facility will add to the company’s presence in the Bay Area.
-
Nautilus Medical Announces Full Suite of Radiology Software Tools at No Cost to Providers to Lower Healthcare Cost in light of Patient Centered Outcomes Research Institute (PCORI)
12/13/2018
The policy advances PCORI's commitment to improve healthcare decision making based upon research.
-
List Labs Announces New Anthrax Lethal Factor Detection Method
12/13/2018
A fast, sensitive, specific and accurate detection method to determine active infection
-
Emeryville Occupational Medical Center Expands to Sacramento
12/13/2018
New state-of-the-art facility continues proven model of prompt treatment with a return to work focus
-
Zymergen Announces $400 Million in Series C Funding led by the SoftBank Vision Fund
12/13/2018
Zymergen, the world’s first molecular manufacturing technology company, announced today it has raised over $400 million in Series C funding led by returning investor SoftBank Vision Fund.
-
BaseHealth Launches First Predictive Analytics Platform Using Patient Laboratory Data to Reveal Hidden Health Risks
12/13/2018
BaseHealth, a predictive health analytics company that empowers health systems and Medicare Advantage (MA) plans to proactively manage rising risk within populations, has introduced the first predictive analytics platform that mines clinical laboratory data, enabling healthcare organizations (HCOs) to improve population health, boost quality scores and optimize risk adjustment.
-
Ayasdi Wins Fierce Innovation Award for Analytics Excellence
12/13/2018
Company honored for intelligent application that reduces clinical variation, improving quality of care and lowering costs
-
Adynxx Announces Notice Of Award For $5.7M In Federal Grant Funding
12/13/2018
Award intended to fund Phase 2 study of brivoligide in patients undergoing mastectomy
-
University of Iowa Health Care Chooses Zingbox to Achieve Holistic Risk Visibility and Operational Benefits
12/13/2018
Leading IoT Security Company Provides Real-time Assessment of Risk Across University of Iowa Health Care’s Network of IoT Devices With Alerts and Guidance for Threat Response
-
Jeff Jonker Joins Ambys Medicines as President and CEO
12/13/2018
Company pursuing novel modalities including cell and gene therapies to regenerate the liver and restore liver function across multiple liver diseases
-
Distributed Bio Inc and Good Therapeutics, Inc. Announce Multi-Target Collaboration
12/12/2018
Distributed Bio, the global leader in computational optimization of fully human monoclonal antibody libraries, today announced a multi-target partnership with Good Therapeutics Inc.
-
Steep Hill Arkansas Open House with Dedication Ceremony
12/12/2018
Ribbon Cutting and Remarks by Cannabis Industry Leader Steve DeAngelo
-
Caliva Announces Additional Cannabis Delivery Base for California Consumers
12/12/2018
Caliva, known as "The Most Trusted Brand in Cannabis," announced today the opening of its new 20,000 square-foot facility in Brisbane, California.
-
Taking A Stand 4 Lyme: Scientists Tackle the Lyme Disease Epidemic
12/12/2018
In Stand4Lyme Foundation's new video, experts address the serious global consequences of Lyme and tick-borne diseases
-
New Research Shows Improving Customer Reference Data Quality Top Priority for Life Sciences
12/12/2018
There is a significant industrywide shift underway to improve the quality of customer data, according to new research by Veeva Systems (NYSE:VEEV).
-
Oncolytics Biotech® Announces First Patient Treated in Study Combining Pelareorep, Carfilzomib and the Checkpoint Inhibitor Opdivo® in Multiple Myeloma
12/12/2018
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced that the first patient was treated in a phase 1 dose escalation study combining pelareorep and carfilzomib with Bristol-Myers Squibb’s checkpoint inhibitor Opdivo®(nivolumab) to treat relapsed multiple myeloma patients.
-
PrinterPrezz Opens First Bay Area 3D Print and Nanotech Innovation Center for Design, Development and Manufacturing of Advanced Medical Devices
12/12/2018
PrinterPrezz Inc., a trailblazer in combining metal 3D printing, nanotechnologies and surgical expertise to design and manufacture next generation medical devices, today announced the opening of its first Innovation Center in the Silicon Valley.
-
Five Prime Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
12/12/2018
Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today announced that Aron Knickerbocker, Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference, Wednesday, January 9, 2019 at 2:00 pm PT.
-
Caribou Biosciences Appoints Dr. Natalie Sacks to Board of Directors
12/12/2018
Dr. Sacks is an accomplished industry leader and oncology expert who has played a key role in the development and approval of several oncology therapeutics.